Pipeline report flags continued pressure The insurer's annual outlook, aimed at private plan sponsors, lists GLP-1 therapies among the leading themes of 2026 and warns that ongoing launches of newer, more expensive drugs are putting increased financial pressure on private drug plans [Source: ab.bluecross.ca/plans/group/drug-pipeline-2026.php]
Anti-Aging: No substantial evidence to support anti-aging claims
5 (Vitamin E also supports hair!) Youll find all three in colorful whole foods: sweet potatoes, carrots, leafy greens, citrus, bell peppers, nuts, and seeds
studies suggest this helps preserve muscle while you lose weight
The incidence of NAION was 17 events in the semaglutide group compared to 6 in the non-GLP-1 RA group
Fewer Side Effects, Including Constipation Relief Constipation is one of the most common side effects of semaglutide, affecting as many as 12% to 35% of people on Ozempic or Wegovy